4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Alector, Inc. (ALEC) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 103 employees. Its market capitalization is roughly $164 million. In the fiscal year ended 2025-12-31, ALEC reported $21M in revenue and ($143M) in net income.
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States.
Interactive charts & full statements → Open the ALEC valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $21M | $101M | $97M | $134M |
| Operating Income (EBIT) | ($156M) | ($145M) | ($152M) | ($138M) |
| Net Income | ($143M) | ($119M) | ($130M) | ($133M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $6M | $3M | $8M | $4M |
| Operating Income (EBIT) | ($25M) | ($40M) | ($38M) | ($34M) | ($45M) |
| Net Income | ($23M) | ($37M) | ($35M) | ($30M) | ($40M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $293M | $468M | $622M | $788M | — |
| Total Liabilities | $263M | $342M | $488M | $573M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ALEC viewer.
About TickerBase · Data methodology & sources